This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

BLACK FRIDAY SAVINGS END IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

David Flowers, Ph.D.
Director, ABS at Certara
Speaker

Profile

Dr. David Flowers is a quantitative systems pharmacology modeler with years of experience supporting drug programs across the pipeline involving various modalities and indications. He earned his Ph. D. at the Massachusetts Institute of Technology in biological engineering, developing a QSP model of the complement system. Since then, he has worked as a modeler at Applied BioMath/Certara, supporting dozens of projects involving T-cell engagers, checkpoint inhibitors, immunocytokines, gene therapies, targeted protein degraders, and other modalities to support lead candidate selection and optimization, dose selection, study design, and other aspects of drug development. Dr. Flowers has authored a paper on innovations he developed for QSP models of T-cell engagers, as well as several other papers and posters.

David Flowers, Ph.D.'s Network

Agenda Sessions

  • Bridging the In Vitro to In Vivo Gap for T-cell Engagers Using QSP Modeling

    3:15pm